CD5+ Relapsed/ RefractoryHematopoietic Malignancies;Chronic LymphocyticLeukemia (CLL); MantleCell Lymphoma (MCL);Diffuse Large B-cellLymphoma (DLBCL);Follicular Lymphoma (FL);Peripheral T-cell Lymphomas(PTCL). This evidence concerns the gene CD5 and mantle cell lymphoma.